Kenex v. USA Kenex Ltd. v. United States of America
United States of America
Manufacturing, marketing and distributing company of industrial products made from the cannabis plant.
Claims arising out of the Drug Enforcement Administration’s interpretation of the Controlled Substances Act as prohibiting the sale of products that cause the controlled substance THC to enter the human body.
Secondary: C - Manufacturing
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
None (no administering institution)
Tribunal not constituted
20.00 mln USD
Data not available
Fair and equitable treatment/Minimum standard of treatment, including denial of justice claims

National treatment

Most-favoured nation treatment
Not applicable - settled or discontinued before decision on liability